SCHEMBL4575175

SCHEMBL4575175

CCc1cnc(N(Cc2ccc(OC(F)(F)F)cc2)CC(C)(C)c2ccc(O)cc2)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 2/20 0.39
RXRA P19793 2/20 0.38
GRIN1 Q05586 2/20 0.38
GRIN2B Q13224 2/20 0.38
NR1H2 P55055 2/20 0.36
NR1H3 Q13133 2/20 0.36
EPHX2 P34913 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
SCN10A Q9Y5Y9 1/20 0.35
CETP P11597 2/20 0.35
TSHR P16473 1/20 0.34
CNR2 P34972 1/20 0.34
PRMT6 Q96LA8 1/20 0.33
LSS P48449 1/20 0.33
SLC6A4 P31645 1/20 0.33
PDK1 Q15118 1/20 0.33
CACNA1H O95180 1/20 0.33
VNN1 O95497 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4575338 0.88 PPARA (0.42) TRPM8
SCHEMBL4575710 0.87 NR1H2 (0.39) TRPM8RXRAGRIN1GRIN2BNR1H2
SCHEMBL4576109 0.87 SMN1; SMN2 (0.42) TRPM8EPHX2NR1H4
Phenol SCHEMBL4575505 0.86 TRPM8 (0.37) TRPM8NR1H2NR1H3CETPCNR2
SCHEMBL4574823 0.85 NR1H2 (0.40) TRPM8RXRAGRIN1GRIN2BNR1H2
SCHEMBL14277910 0.84 RXRA (0.33) TRPM8RXRAGRIN1GRIN2BSCN10A
SCHEMBL4575060 0.84 BCHE (0.43) TRPM8RXRAGRIN1GRIN2BNR1H2
SCHEMBL4575614 0.83 TRPM8 (0.37) TRPM8RXRAGRIN1GRIN2B
SCHEMBL4575939 0.83 NR1H2 (0.37) TRPM8RXRAGRIN1GRIN2BNR1H2
SCHEMBL4574756 0.83 PPARA (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-20050137212-A1 Hppars activators SMITHKLINE BEECHAM CORPORATION 2005-06-23 US disclosed
EP-1480957-A1 HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2004-12-01 EP disclosed
WO-2003074495-A1 HPPARS ACTIVATORS SMITHKLINE BEECHAM CORPORATION (US) 2003-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137212-A1 Hppars activators PPARG, PPARA, PPARD TRPM8 1027/4885RXRA 27/4885GRIN1 1829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.